Loading company…
Sable Therapeutics develops non-invasive technologies for fat reduction and body contouring.
Sable Therapeutics is developing technology that targets adipose tissue through non-invasive fat reduction methods. Its intended users include consumers, wellness clinics and cosmetic surgeons. Founded in 2020 and based in New York, US, the company raised an undisclosed amount of Seed funding from SOSV in September 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in